First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET amplification after ...
Maryland Gov. Wes Moore said he plans to introduce a balanced budget that prioritizes education and safety in the final ...
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presenceNext-generation ...
Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in ...
Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...
(Alliance News) - Hutchmed China Ltd on Wednesday said the results from its SACHI phase-three lung cancer trial have been published in medical journal the Lancet.
The first two days of the J.P. Morgan Healthcare Conference are in the books, and attendees are now pushing through to finish ...
MedPage Today on MSN
Flu antiviral use among hospitalized kids fell during COVID pandemic
Among 1,560 kids hospitalized with the flu, antiviral use ranged between 48.3% and 56.8% in the years before the pandemic, ...
The firm expects Phase III data for its investigational selective estrogen receptor degrader camizestrant and its CLDN18.2 ADC sonesitatug vedotin this year.
New research presented at ASCO GI positions both agents as potent therapeutic options, with potential to redefine standard ...
The house dust mite disease market is experiencing steady growth, driven by rising global prevalence of allergic rhinitis and asthma linked to indoor ...
The generalized myasthenia gravis market in 7MM is expected to show positive growth during the forecast period (2025–2034), mainly driven by the anticipated launch of emerging therapies such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback